We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Measures of adiposity in childhood and adolescence may be related to cord blood leptin and adiponectin levels, markers of neonatal fat mass, according to study findings recently published in The Journal of Clinical Endocrinology & Metabolism.
Perspective from
Scott M. Nelson, PhD, Muirhead professor of obstetrics and gynecology, University of Glasgow in the United Kingdom, and colleagues evaluated data from the Avon Longitudinal Study of Parents and Children to determine whether neonatal fat mass is associated with adiposity in children at age 9 years (n = 2,775) and adolescents at age 17 years (n = 2,138).
Scott M. Nelson
Cord blood leptin (r = 0.33) and cord blood adiponectin (r = 0.14) were positively associated with birth weight. At age 9 years, higher cord blood leptin was associated with fat mass, waist circumference and BMI; this association was insignificant at age 17 years after adjustment for potential confounders.
Cord blood adiponectin was positively associated with fat mass and waist circumference at age 17 years, but not at age 9 years.
“In a longitudinal study of more than 2,000 children we found that cord blood leptin and adiponectin, known surrogates of fetal fat mass, were weakly positively associated with some measures of fat mass in late childhood and adolescence,” Nelson told Endocrine Today. “That the associations were robust to a wide range of confounders that reflect intrauterine, maternal and shared environmental exposures suggests that neonatal fat mass may track into later life. However, the magnitude of the observed associations is small, potentially limiting the impact that neonatal life adiposity has on later outcomes. Moving forward replication of these findings in other longitudinal birth cohorts would be useful.” – by Amber Cox